Early Detection of Advanced Adenomas and Colorectal Cancer
NCT06342440
This study is recruiting at 2 US sites in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
This study aims to develop a highly sensitive, specific, and cost-effective blood assay for early detection of colorectal adenomas and cancer, using advanced machine learning and state-of-the-art biological analyses.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Colorectal Cancer
- Colorectal Neoplasms
- Colorectal Polyp
- Colorectal Adenocarcinoma
- Colorectal Disorders
- Colorectal Dysplasia
- Colorectal Cancer Stage I
- Colorectal Cancer Stage II
- Colorectal Cancer Stage III
- Colorectal Cancer Stage IV
- Colorectal Neoplasms Malignant
- Colorectal Serrated Adenocarcinoma
- Colorectal Adenoma With Severe Dysplasia
- Colorectal Adenoma With Mild Dysplasia
- Colorectal Adenoma With Moderate Dysplasia
- Colorectal Adenoma and Carcinoma 1
- Colorectal Adenomatous Polyp
- Colorectal Adenocarcinoma Metastatic in the Liver
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- City of Hope Medical Center
- Last updated on ClinicalTrials.gov
- July 7, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
California · 2
- City of Hope Medical Center · Monrovia, CA
- University of California San Diego · San Diego, CA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.